Splash Pharmaceuticals
San Diego
About Splash Pharmaceuticals
Splash is a privately held company that is developing novel cancer therapies with a goal to provide dramatic and durable responses in many solid tumors. Splash has developed a pipeline of novel agents that target CD44 with demonstrated anti-angiogenic and anti-metastatic activity as well as synergistic cytotoxicity with other chemotherapy agents. Splash is actively seeking Pharma partners to accelerate its novel clinical programs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $23.0M
- Funding stage: Late Stage Venture
- Last round: Series D (May 2018)
- Website: splashpharma.com
Industries & Categories
Biotechnology, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/splash-pharmaceuticals-2443873 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.